PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The First Department of Infectious Disease.\', \'The Intensive Care Unit.\', \'The Radiology Department.\', \'The Second Department of Infectious Disease, The Ninth Hospital of Nanchang, Nanchang 330002, Jiangxi Province.\', \'Ascletis Bioscience Co., Ltd., Hangzhou 310051.\', \'Ascletis Pharmaceuticals Co., Ltd., Shaoxing 310051, Zhejiang Province, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/MD.0000000000023357
?:hasPublicationType
?:journal
  • Medicine
is ?:pmid of
?:pmid
?:pmid
  • 33235105
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.105
?:rankingScore_hIndex
  • 4
is ?:relation_isRelatedTo_publication of
?:title
  • First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33235105>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33235105>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all